Safety and Tolerability of Antibody-Drug Conjugates in Cancer

Overview of attention for article published in Drug Safety, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 1 X user
patent: 3 patents

f1000: 1 research highlight platform

Citations

dimensions_citation: 80 Dimensions

Readers on

mendeley: 164 Mendeley

Summary X Patents Research highlights Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

COMPOSITIONS AND METHODS FOR REDUCING OFF-TARGET TOXICITY OF ANTIBODY DRUG CONJUGATES

Application EP-4069312-A4

European Patent Office

METHODS FOR TREATMENT OF CD20-POSITIVE PROLIFERATIVE DISORDER WITH MOSUNETUZUMAB AND…

Application US-20220411528-A1

United States of America

Monoclonal antibody targeting a unique sialoglycosylated cancer-associated epitope of CD43

Grant US-11174318-B2

United States of America